论文部分内容阅读
目的探讨人血清表皮生长因子(hEGF)水平与胃癌的关系.方法胃癌患者33例,男30例,女3例,年龄35岁~81岁,平均649岁;慢性胃炎患者38例,男25例,女13例,年龄18岁~75岁,平均432岁;正常人20例,男10例,女10例.应用RIA法检测血清中的hEGF.结果胃癌组血清hEGF(μg/L)为135±067,正常对照组为090±033,统计学差异非常显著(t=2825,P<001),慢性胃炎组血清hEGF为086±033,与正常对照组比较差异无显著性(t=041,P>005).结论胃癌患者血清hEGF水平升高可能与胃癌发生密切相关.
Objective To investigate the relationship between human serum epidermal growth factor (hEGF) levels and gastric cancer. Methods Thirty-three patients with gastric cancer included 30 males and 3 females, aged 35 to 81 years old, with an average of 64 9 years old; 38 patients with chronic gastritis, 25 males and 13 females, aged 18 to 75 years old, average 43 2 years old; normal 20 cases, 10 males and 10 females. Detection of hEGF in serum by RIA. Results The serum hEGF (μg/L) was 135±067 in the gastric cancer group and 090±033 in the normal control group. The statistical difference was significant (t=2825, P<001). The serum hEGF of chronic gastritis group was 086±033. There was no significant difference from the normal control group (t=041, P>005). 2. Conclusions The increase of serum hEGF levels in gastric cancer patients may be closely related to the occurrence of gastric cancer.